Torrence et al., 1993 - Google Patents
Synthesis and pharmacokinetics of a dihydropyridine chemical delivery system for the antiimmunodeficiency virus agent, dideoxycytidineTorrence et al., 1993
- Document ID
- 13457608073737011055
- Author
- Torrence P
- Kinjo J
- Khamnei S
- Greig N
- Publication year
- Publication venue
- Journal of medicinal chemistry
External Links
Snippet
Results Chemistry. Synthesis (Scheme I). In one potential approach to derivatizing DDC (1) with a dihydropyridine redox system, one could envision synthesis of a nicotinate ester which would then be quatemized with methyl iodide to yield the N-methylpyridinium …
- 230000015572 biosynthetic process 0 title abstract description 12
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48007—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent
- A61K47/48023—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent the modifying agent being an organic compound
- A61K47/48061—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent the modifying agent being an organic compound the modifying agent being a heterocyclic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69731758T2 (en) | O2-ARYLATE OR O2 GLYCOSYIATE 1-SUBSTITUTED DIAZEN-1-IUM-1,2-DIOLATE AND O2-SUBSTITUTED 1 (2-CARBOXYLATE) PYROLIDIN-1-YL DIAZEN-1-IUM-1,2-DIOLATE | |
| Palomino et al. | A dihydropyridine carrier system for sustained delivery of 2', 3'-dideoxynucleosides to the brain | |
| Prokai et al. | Targeting drugs to the brain by redox chemical delivery systems | |
| Marquez et al. | Acid-stable 2'-fluoro purine dideoxynucleosides as active agents against HIV | |
| Henin et al. | Lipophilic glycosyl phosphotriester derivatives of AZT: synthesis, NMR transmembrane transport study and antiviral activity | |
| DE3856557T2 (en) | Acyl deoxyribonucleoside derivatives and uses thereof | |
| Torrence et al. | Synthesis and pharmacokinetics of a dihydropyridine chemical delivery system for the antiimmunodeficiency virus agent, dideoxycytidine | |
| AU713466B2 (en) | Carbohydrate-modified cytostatics | |
| DE19720312A1 (en) | Preparation with increased in vivo tolerance | |
| JPH01294663A (en) | Redox system for supply dryg aiming brain | |
| UA64797C2 (en) | Farnesyl protein transferase inhibitors as for pharmaceutical substances for treating arthropathies | |
| EP0595133A2 (en) | Prodrugs, their preparation and use as medicaments | |
| DE4111730A1 (en) | NEW CYTARABIN DERIVATIVES, THEIR PRODUCTION AND USE | |
| DE102009051799A1 (en) | Bifunctional prodrugs and drugs | |
| KR19990076695A (en) | Active Agents and Methods for Treating Diseases Associated with Overexpression of Cytidine Deaminase or Deoxycytidine Deaminase | |
| US5602278A (en) | N-oxides and derivatives of chlorambucil for treating hypoxic tumor cells | |
| EP2646449B1 (en) | Uridine di- or tri-phosphate derivatives and uses thereof | |
| EP0817790B1 (en) | Specific lipid conjugates of nucleoside diphosphates and their use as drugs | |
| SI20976A (en) | Compositions and methods for l-nucleosides, l-nucleotides, and their analogs | |
| Hunston et al. | Synthesis of 2′-deoxy-5-fluoro-5′-O-1 ″, 3 ″, 2 ″-oxazaphosphacyclohexa-2 ″-yluridine 2 ″-oxide and related compounds | |
| DE69332304T2 (en) | ANTIVIRAL 2 ', 5'-OLIGOADENYLATE DERIVATIVES WITH DOUBLE EFFECT AND THEIR USE | |
| EP1135401A1 (en) | Glyceryl nucleotides, method for the production thereof and their use | |
| DE69624236T2 (en) | SELECTED SOLUBLE ESTERS OF INDOLCARBAZOLES CONTAINING HYDROXYL | |
| RU2418795C2 (en) | Dioxolane derivatives for cancer treatment | |
| Wilman et al. | Molecular structure and antitumour activity of alkylating agents |